MedTrace Logo

Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction

NCT01559922 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2019-11-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether Artefill is safe and effective for the correction of atrophic facial acne scars.

Conditions

  • Atrophic Acne Scar

Interventions

DRUG

Normal Saline

Administration of up to 2 study treatments administered 6 weeks apart

DEVICE

Artefill

Administration of up to 2 study treatments administered 6 weeks apart

Sponsors & Collaborators

  • ethica Clinical Research Inc.

    collaborator INDUSTRY

  • Suneva Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Nancy Serreta · Suneva Medical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-04-30
Completion
2014-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01559922 on ClinicalTrials.gov